These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 20953746

  • 21. Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial.
    Ratjen F, Davis SD, Stanojevic S, Kronmal RA, Hinckley Stukovsky KD, Jorgensen N, Rosenfeld M, SHIP Study Group.
    Lancet Respir Med; 2019 Sep; 7(9):802-809. PubMed ID: 31178421
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function.
    Amin R, Subbarao P, Jabar A, Balkovec S, Jensen R, Kerrigan S, Gustafsson P, Ratjen F.
    Thorax; 2010 May; 65(5):379-83. PubMed ID: 20435858
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Inhalation of hypertonic saline: a promising therapy in bronchiectasis].
    Koskela H, Purokivi M.
    Duodecim; 2011 May; 127(24):2653-9. PubMed ID: 22320108
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Hypertonic saline for cystic fibrosis.
    Kuver R, Lee SP.
    N Engl J Med; 2006 Apr 27; 354(17):1848-51; author reply 1848-51. PubMed ID: 16642591
    [No Abstract] [Full Text] [Related]

  • 32. Clinical value of obtaining sputum and cough swab samples following inhaled hypertonic saline in children with cystic fibrosis.
    Ho SA, Ball R, Morrison LJ, Brownlee KG, Conway SP.
    Pediatr Pulmonol; 2004 Jul 27; 38(1):82-7. PubMed ID: 15170878
    [Abstract] [Full Text] [Related]

  • 33. Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis.
    Dellon EP, Donaldson SH, Johnson R, Davis SD.
    Pediatr Pulmonol; 2008 Nov 27; 43(11):1100-1106. PubMed ID: 18828160
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A randomised trial of hypertonic saline during hospitalisation for exacerbation of cystic fibrosis.
    Dentice RL, Elkins MR, Middleton PG, Bishop JR, Wark PA, Dorahy DJ, Harmer CJ, Hu H, Bye PT.
    Thorax; 2016 Feb 27; 71(2):141-7. PubMed ID: 26769016
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature.
    Boogaard R, de Jongste JC, Merkus PJ.
    Pediatr Pulmonol; 2007 Nov 27; 42(11):989-1001. PubMed ID: 17902149
    [Abstract] [Full Text] [Related]

  • 38. Impact of Hypertonic Saline Solutions on Sputum Expectoration and Their Safety Profile in Patients with Bronchiectasis: A Randomized Crossover Trial.
    Herrero-Cortina B, Alcaraz V, Vilaró J, Torres A, Polverino E.
    J Aerosol Med Pulm Drug Deliv; 2018 Oct 27; 31(5):281-289. PubMed ID: 29878856
    [Abstract] [Full Text] [Related]

  • 39. [New opportunities for inhaled therapy for inflammatory diseases of the respiratory system].
    Ignatova GL, Antonov VN.
    Ter Arkh; 2017 Oct 27; 89(8):110-112. PubMed ID: 28914860
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.